2013 VAM: 4817 New Tools to Make Specific Immunotherapy More Specific
Virtual Annual Meeting Recordings
AMA PRA Category 1 CreditsTM: 1.25
CE Units: 1.50
Upon completion of this session, participants should be able to:
- Debate how using new diagnostic tools might improve the specific selection of immunotherapy.
- Review the status of immunotherapy with recombinant, modified recombinant and peptide molecules and on the safety profiles of these options.
- Discuss the other application forms being evaluated in clinical trials and which pitfalls still have to be overcome by this treatment modality to offer a viable alternative to standard immunotherapy.
System Requirements: Two most recent versions of Internet Explorer, Safari, Google Chrome, and Firefox. Pop-ups must be enabled to view content.
- 1.25 AttendanceAttendance credit.
- 1.50 CECE credit.
- 1.25 CMECME credit.